Table 2.
25(OH)D | ||||
Normal | Insufficient | Deficient | p-trend | |
Spring | ||||
Range (nmol/L) | 10.0–17.8 | 17.9–35.2 | ≥35.3 | |
Events | 281 | 186 | 33 | |
Person-years | 319,338 | 146,930 | 24,354 | |
Incidence | 0.9 | 1.3 | 1.4 | |
HR (95% CI), Model 1 | 1.0 | 1.5 (1.2–1.8) | 1.6 (1.1–2.3) | <0.0001 |
HR (95% CI), Model 2 | 1.0 | 1.5 (1.3–1.8) | 1.6 (1.1–2.3) | <0.0001 |
Summer | ||||
Range (nmol/L) | 10.0–28.0 | 28.1–50.4 | ≥50.5 | |
Events | 314 | 179 | 55 | |
Person-years | 302,662 | 137,969 | 22,775 | |
Incidence | 1.0 | 1.3 | 2.41 | |
HR (95% CI), Model 1 | 1.0 | 1.3 (1.1–1.6) | 2.5 (1.9–3.3) | <0.0001 |
HR (95% CI), Model 2 | 1.0 | 1.3 (1.1–1.5) | 1.9 (1.4–2.6) | <0.0001 |
Autumn | ||||
Range (nmol/L) | 10.0–24.0 | 24.1–46.2 | ≥46.3 | |
Events | 263 | 140 | 52 | |
Person-years | 272,827 | 125,247 | 20,621 | |
Incidence | 1.0 | 1.1 | 2.5 | |
HR (95% CI), Model 1 | 1.0 | 1.2 (1.0–1.5) | 2.7 (2.0–3.7) | <0.0001 |
HR (95% CI), Model 2 | 1.0 | 1.1 (0.9–1.4) | 2.1 (1.5–2.9) | <0.0001 |
Winter | ||||
Range (nmol/L) | 10.0–16.9 | 17.0–33.4 | ≥33.5 | |
Events | 217 | 122 | 32 | |
Person-years | 227,625 | 10,4421 | 17,049 | |
Incidence | 1.0 | 1.2 | 1.9 | |
HR (95% CI), Model 1 | 1.0 | 1.3 (1.0–1.6) | 2.1 (1.4–3.0) | 0.0002 |
HR (95% CI), Model 2 | 1.0 | 1.2 (0.9–1.5) | 1.7 (1.1–2.5) | 0.0246 |
Combined | ||||
Events | 1,075 | 627 | 172 | |
Person-years | 1,122,451 | 514,566 | 84,800 | |
Incidence | 1.0 | 1.2 | 2.0 | |
HR (95% CI), Model 1 | 1.0 | 1.3 (1.2–1.5) | 2.2 (1.9–2.6) | <0.0001 |
HR (95% CI), Model 2 | 1.0 | 1.3 (1.1–1.4) | 1.8 (1.6–2.2) | <0.0001 |
Incidence of dementia represents number of cases per 1000 person-years. Hazard ratio (95% CI) for incident dementia associated with 25(OH)D status was estimated using Cox proportional regression models. Model 1 was adjusted for age and gender; Model 2 was adjusted for model 1 plus the day of the year when serum was collected, ethnicity, education, income, diet score, 25(OH)D supplement, smoking, alcohol consumption, sleep, physical activity, BMI, cholesterol, glycosylated hemoglobin, cystatin C, depression, hypertension, diabetes, heart disease, and chronic kidney disease at baseline.